Abstract

Paragangliomas, a type of extra-adrenal tumour, albeit rare, are dangerous due to their high metastatic potential and risk of hypertensive crisis from massive catecholamine release. It typically presents with sympathetic overdrive symptoms such as diaphoresis, headache, and palpitation, accompanied by substantially high plasma metanephrines level and mass on contrasted computed tomography abdomen and pelvis, whilst some are found incidentally. In this report, we discuss a case of an extra-adrenal lesion located near susceptible major structures with extensive vascularisation, in a patient with near-death experience. Complete excision of the pulsatile mass with minimal bleeding and no complications, was made possible utilizing the da Vinci Robotic System. Robotic surgery, being a part of a multidisciplinary approach, leads to better patient outcomes and shorter hospitalisations. Moreover, it offers enhanced dexterity and improved depth perception compared to conventional methods. However, further studies are needed to validate its application in standard practice.

Introduction

Despite the growing popularity of robotic surgery, there have been limited reports on paraganglioma excisions. Paragangliomas, tumours that derive from extra-adrenal chromaffin tissue, are commonly found at the organ of Zuckerkandl, located between the aortic bifurcation and inferior mesenteric artery [1–3]. Although having a low combined annual incidence of 0.8 per 100 000 person-years, and a prevalence of 6 per 1 million persons [4], it causes significant cardiovascular mortality and morbidity during hypertensive crisis from excess catecholamine release. According to the 8th edition of the American Joint Committee on Cancer on tumour, node, metastasis staging, all extra-adrenal paragangliomas are classified as T2, stage 2 tumours due to high metastatic potential [5, 6]. Hence, surgical resection remains the gold standard in treating paragangliomas to address secondary hypertension, improve glycaemic levels, and mitigate the risk of metastasis [1, 4]. This paper aims to document a case involving robotic extirpation for a pulsatile mass located at the organ of Zuckerkandl.

Case report

A 30-year-old urology registrar presented to the emergency department complaining of headache, nausea and abdominal pain, and was found to be hypertensive. He became very agitated whilst on the ward and was intubated. A computed tomography (CT) of the brain was normal, but subsequent CT of his abdomen and pelvis revealed a 2 × 2 × 3 cm hypervascular mass adjacent to his aorta just above the bifurcation. Initially suspected to be an aneurysm, it was later identified as a paraganglioma (Figs 1 and 2). He was then referred to the endocrine surgery team.

Contrasted CT in arterial phase, in the axial plane, showed a contrast enhanced, hyperdense, heterogenous lesion located over the left para-aortic region, measuring ⁓2 × 2 × 3 cm with no septations or peripheral rim enhancement.
Figure 1

Contrasted CT in arterial phase, in the axial plane, showed a contrast enhanced, hyperdense, heterogenous lesion located over the left para-aortic region, measuring ⁓2 × 2 × 3 cm with no septations or peripheral rim enhancement.

Contrasted CT of the abdomen and pelvis in arterial phase, coronal plane, revealed a similar mass, contrast enhanced heterogenous lesion with well demarcated borders, measuring ⁓2 × 2 × 3 cm, situated at the left para-aortic region.
Figure 2

Contrasted CT of the abdomen and pelvis in arterial phase, coronal plane, revealed a similar mass, contrast enhanced heterogenous lesion with well demarcated borders, measuring ⁓2 × 2 × 3 cm, situated at the left para-aortic region.

The team advised on starting Doxazosin for blood pressure stabilization, after which he was extubated and discharged. His free plasma normetanephrine was markedly raised at 3600 pmol/L (0–510 pmol/L), whilst other parameters were normal.

Given the risk of hypertensive crisis causing stroke or sudden death, urgent tumour removal was advised. His consent was obtained after the surgical risks including bleeding, infection, damage to surrounding structures and perioperative risk of stroke, myocardial infarction and death was explained. He was also referred to a geneticist for genetic test counselling due to a family history of cancer.

Preoperative alpha receptor blockade with 10 mg Phenoxybenzamine was given three times a day for 4 weeks to optimize blood pressure.

He underwent a robotic excision of his paraganglioma in a right lateral position, using a transperitoneal approach with three robotic ports and one assistant port in the midline. The left colon was mobilized medially, exposing the tumour. After identifying the ureter and gonads, the tumour was dissected freely using a vessel sealer, before removing it in a specimen bag. Operation was uneventful (Figs 3 and 4).

Well circumscribed mass with extensive vascularisation is located and isolated, with no surrounding tissue necrosis or invasion observed. Real time video footage revealed a pulsatile mass.
Figure 3

Well circumscribed mass with extensive vascularisation is located and isolated, with no surrounding tissue necrosis or invasion observed. Real time video footage revealed a pulsatile mass.

Post tumour removal showed clean base with no active bleeding. No evidence of tissue invasion into peripheral structures.
Figure 4

Post tumour removal showed clean base with no active bleeding. No evidence of tissue invasion into peripheral structures.

Histopathological lab reported a 35 mm sympathetic paraganglioma completely excised with clear margins, supported by presence of positive staining for synaptophysin, chromogranin, and S100 seen in sustentacular cells. Postoperative follow-up confirmed normal biochemical parameters with no complications.

Discussion

Chromaffin cell tumours usually stem from adrenal medullas, with only 15% occurring extra-adrenally as paragangliomas [7]. Functional paragangliomas display sympathetic overdrive symptoms such as diaphoresis, headache, palpitations, and hypertension [3]. Free plasma metanephrines test is preferred for screening due to its high diagnostic accuracy and relatively simple process [1, 8].

CT scans of the abdomen and pelvis remain the preferred radiological method in diagnosing both active and silent paragangliomas, demonstrating 90% sensitivity and 93% specificity in identifying extra-adrenal tumours. These tumours typically appear as contrast-enhanced lesions with central hypoattenuation [8–10].

Preoperative administration of alpha-adrenergic receptor antagonist, followed by beta-adrenergic receptor to prevent unopposed stimulation of alpha-adrenergic receptor causing hypertensive crisis [8], is recommended for all patients to reduce intra-operative BP fluctuations, prevent cardiovascular complications, and lower overall mortality rate [2, 11].

Next, for definitive management, although some advocate open resection for paragangliomas due to its narrow site, malignant potential, presence of synchronous multifocal tumour, and need for contiguous organ resection, others suggested minimally invasive resection with laparoscopy or robotic arms to be the standard of care for small paragangliomas with clear resection margins [1, 8].

Laparoscopic retroperitoneal paraganglioma excision incurs difficulties due to technical limitations including restricted instruments’ range of motion, exacerbated by deep tumour location and its proximity to important structures [12]. Well equipped with 7 degrees of freedom, clear visual feedback in three dimensions, and stable robotic arms [2, 12], robotic surgery provides better dexterity allowing easy suturing and knotting, improved depth perception and spatial awareness, plus eliminates unstable instrument handling due to surgeons' fatigue with better ergonomics, enabling meticulous dissection, tedious haemostasis, and minimal tumour manipulation [3, 12, 13]. In addition to the United States Food and Drug Administration's approval [14], various studies on robotic excision of retroperitoneal tumours, reported positive outcomes including shorter postoperative hospital stay, lesser estimated blood loss, and lower conversion to open surgery, with similar morbidity and mortality rates, when compared to laparoscopic approach [3, 11, 12]. Interestingly, Naranjo et al. [11] reported similar treatment costs between laparoscopic and robotic surgery, factoring in the higher expenses of extended hospitalization, compared to more expensive robotic equipments. On the other hand, absence of tactile feedback and increased operative time may deter the usage of robotic surgery, which may be overcome with more training and experience [2, 11, 13].

Postoperative monitoring is imperative due to risk of hypotension from sudden drop in catecholamine levels and potential hypoglycaemia caused by hyperinsulinemia stimulated by chronic catecholamines excess [15]. Regular biochemical testing for catecholamine levels after surgery is essential for monitoring recurrence or metastasis [8].

Formal diagnosis of paragangliomas is confirmed through histopathology, with characteristic sustentacular cells stained positively for S100 and SOX10 [5]. Preoperative biopsies are avoided to minimize risks of inflammation and catecholamine leakage.

As paragangliomas are commonly associated with hereditary cancer syndromes, genetic testing shall be routinely offered [8].

In conclusion, paraganglioma extirpation is unique and intricate due to its hormonal properties, high metastatic potential, extensive vascularisation, and difficult location. Robotic surgery presents as a better alternative to conventional methods, by offering improved dexterity, better ergonomics, and clearer three-dimensional view whilst eliminating wobbly instrument usage. However, further studies on robotic paraganglioma excision are needed to confirm the safety and benefits of using robotic surgery in complex cases.

Acknowledgements

I would like to express my heartfelt gratitude to my supervisor, Mr Jason Ramsingh, for his invaluable guidance and support throughout the process of writing this case report. His exceptional skills in robotic surgery were instrumental in the success of this procedure. Much appreciation is given to the endocrinologist, anaesthetist, nurses and other healthcare professionals in Royal Victoria Infirmary, Newcastle in delivering the best care for this patient. I would also like to thank the patient for his support and consent for his experience to be written.

Conflict of interest statement

None declared.

Funding

None declared.

References

1.

Goers
TA
,
Abdo
M
,
Moley
JF
, et al.
Outcomes of resection of extra-adrenal pheochromocytomas/paragangliomas in the laparoscopic era: a comparison with adrenal pheochromocytoma
.
Surg Endosc
2013
;
27
:
428
33
. .

2.

Park
JS
,
Lee
KY
,
Kim
JK
, et al.
The first laparoscopic resection of extra-adrenal pheochromocytoma using the da Vinci® robotic system
.
J Laparoendoscopic Adv Surg Tech
2008
;
19
:
63
5
. .

3.

Handa
A
,
Dash
SC
,
Solanki
N
, et al.
Robotic excision of interaortocaval paraganglioma: a case report with the literature review
.
African J Urol
2021
;
27
:
162
. .

4.

Lenders
JW
,
Kerstens
MN
,
Amar
L
, et al.
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the working group on endocrine hypertension of the European Society of Hypertension
.
J Hypertens
2020
;
38
:
1443
56
. .

5.

Mete
O
,
Asa
SL
,
Gill
AJ
, et al.
Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas
.
Endocr Pathol
2022
;
33
:
90
114
. .

6.

Edge
SB
, American Joint Committee on Cancer.
AJCC Cancer Staging Handbook: from the AJCC Cancer Staging Manual
.
Springer
,
2010
.

7.

Friedman
LR
,
Ramamoorthy
B
,
Nilubol
N
.
Progress in surgical approaches and outcomes of patients with pheochromocytoma and paraganglioma
.
Best Pract Res Clin Endocrinol Metab
2024
;
101954
:
101954
. .

8.

Lenders
JW
,
Duh
QY
,
Eisenhofer
G
, et al.
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline
.
J Clin Endocrinol Metab
2014
;
99
:
1915
42
. .

9.

Han
S
,
Suh
CH
,
Woo
S
, et al.
Performance of 68Ga-DOTA–conjugated somatostatin receptor–targeting peptide PET in detection of pheochromocytoma and paraganglioma: a systematic review and metaanalysis
.
J Nucl Med
2019
;
60
:
369
76
. .

10.

Wiseman
D
,
Lakis
ME
,
Nilubol
N
.
Precision surgery for pheochromocytomas and paragangliomas
.
Horm Metab Res
2019
;
51
:
470
82
. .

11.

Naranjo
J
,
Dodd
S
,
Martin
YN
.
Perioperative management of pheochromocytoma
.
J Cardiothorac Vasc Anesth
2017
;
31
:
1427
39
. .

12.

Oh
JK
,
Yang
MS
,
Yoon
DH
, et al.
Robotic resection of huge presacral tumors: case series and comparison with an open resection
.
J Spinal Disord Tech
2014
;
27
:
E151
4
. .

13.

Ahmed
K
,
Khan
MS
,
Vats
A
, et al.
Current status of robotic assisted pelvic surgery and future developments
.
Int J Surg
2009
;
7
:
431
40
. .

14.

Ballantyne
GH
,
Moll
F
.
The da Vinci telerobotic surgical system: the virtual operative field and telepresence surgery
.
Surg Clin
2003
;
83
:
1293
304
. .

15.

Fassnacht
M
,
Assie
G
,
Baudin
E
, et al.
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN clinical practice guidelines for diagnosis, treatment and follow-up
.
Ann Oncol
2020
;
31
:
1476
90
. .

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.